Galapagos NV
GLPG
#4956
Rank
A$2.61 B
Marketcap
A$38.89
Share price
0.00%
Change (1 day)
-12.14%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): A-$0.84

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.57. In 2024 the company made an earnings per share (EPS) of A$1.63 a decrease over its 2023 EPS that were of A$4.98.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.84
2024A$1.63-67.16%
2023A$4.98-199.64%
2022A-$5.0099.03%
2021A-$2.51-68.98%
2020A-$8.09-298.06%
2019A$4.09-554.64%
2018A-$0.90-77.18%
2017A-$3.94-326.21%
2016A$1.74-134.19%
2015A-$5.09-371.34%
2014A$1.88-445.98%
2013A-$0.5432.88%
2012A-$0.41-82.07%
2011A-$2.28-817.9%
2010A$0.3212.73%
2009A$0.28-120.79%
2008A-$1.35-37.67%
2007A-$2.1739.64%
2006A-$1.5528.17%
2005A-$1.216.25%
2004A-$1.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.25-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.06-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.88-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.59-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$4.99-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.75-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$5.45-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A-$0.86 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.92-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel